China-based startup Everest Medicines has inked two separate definitive agreements with Canadian biotech firm Provi...
China-based Clover Biopharmaceuticals has announced that its wholly-owned subsidiary, Zhejiang Clover Biopharmaceut...
In response to the growing demands of effective cleaning and disinfection practices Whiz Gambit, the 2-in-1 AI-powered c...
Cytiva continues to expand its manufacturing capacity for bioprocessing single-use consumables in China. In collaboratio...
A comprehensive, systematic meta-analysis conducted by scientists at the Hong Kong Baptist University (HKBU) found ...
A recent study by The Faculty of Medicine at The Chinese University of Hong Kong (CU Medicine) showed that the unprecede...
Regencell Bioscience Holdings Limited has announced that Regencell Bioscience, the company’s wholly-owned subsidia...
China-based Insilico Medicine has announced an R&D collaboration with Gray Matter, a longevity biotechnology company...
The Institute for AI Industry Research,Tsinghua University (AIR) and the Beijing Academy of Artificial Intelligence (BAA...
Lynk Pharmaceuticals CO., LTD, an innovative pharmaceutical R&D company, announced that it has successfully complete...
Mabwell (Shanghai) Bioscience Co. Ltd and Singapore's FEGO Biotech Pte Ltd have jointly entered into a co...
China-based startups Insilico Medicine and 4B Technologies have signed a strategic collaboration agreement in ...
Wockhardt Bio, a subsidiary of Wockhardt, a leader in the discovery of novel antibiotics and Jiangxi Jemincare Group Com...
Kintor Pharmaceutical Limited, a clinical-stage biotechnology company developing innovative small molecule and biologica...
OrigiMed has announced that the Human NTRK1/2/3 Genomic Alteration Testing Kit has been granted the Special Review ...
With the ongoing worldwide COVID-19 pandemic, an increasing number of viral variants are being identified, which poses a...
China’s overall focus within oncology research is increasing at a rapid pace. Moreover, the country recently appro...
Zhaoke Ophthalmology has announced that the Phase III clinical trial of one of the company's core drug candidates, Cyclo...
An international research team led by scientists from the Hong Kong University of Science and Technology (HKUST) has dev...
China National Medical Products Administration (NMPA) has approved GC Pharma's GreenGene F (Beroctocog alfa) [Recom...
Hong Kong-based PHASE Scientific International has announced that its INDICAID™ COVID-19 Rapid Antigen Test (...
Hong Kong-based New World Development (NWD) and Prenetics have jointly announced the launch of the Circle HealthPod...
A collaborative study between scientists at the Shanghai University of Traditional Chinese Medicine and AntiCancer Inc. ...
Hong Kong's Antengene Corporation Limited, a biopharmaceutical company focused on hematology and oncology drugs is ...
Shanghai Promega Biological Products and Shanghai Henlius Biotech, Inc. will develop and commercialize a microsatellite ...
